These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19248121)

  • 1. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
    Komano Y; Harigai M; Koike R; Sugiyama H; Ogawa J; Saito K; Sekiguchi N; Inoo M; Onishi I; Ohashi H; Amamoto F; Miyata M; Ohtsubo H; Hiramatsu K; Iwamoto M; Minota S; Matsuoka N; Kageyama G; Imaizumi K; Tokuda H; Okochi Y; Kudo K; Tanaka Y; Takeuchi T; Miyasaka N
    Arthritis Rheum; 2009 Mar; 61(3):305-12. PubMed ID: 19248121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody.
    Mori S; Imamura F; Kiyofuji C; Ito K; Koga Y; Honda I; Sugimoto M
    Mod Rheumatol; 2006; 16(1):58-62. PubMed ID: 16622728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.
    Watanabe K; Sakai R; Koike R; Sakai F; Sugiyama H; Tanaka M; Komano Y; Akiyama Y; Mimura T; Kaneko M; Tokuda H; Iso T; Motegi M; Ikeda K; Nakajima H; Taki H; Kubota T; Kodama H; Sugii S; Kuroiwa T; Nawata Y; Shiozawa K; Ogata A; Sawada S; Matsukawa Y; Okazaki T; Mukai M; Iwahashi M; Saito K; Tanaka Y; Nanki T; Miyasaka N; Harigai M
    Mod Rheumatol; 2013 Nov; 23(6):1085-93. PubMed ID: 23212592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].
    Ikeuchi H; Umemoto A; Tsukida M; Sakurai N; Maeshima A; Kuroiwa T; Hiromura K; Nojima Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):420-5. PubMed ID: 22041430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbation of interstitial pneumonia associated with rheumatoid arthritis during the course of treatment for Pneumocystis jirovecii pneumonia: a case report.
    Kuroda T; Takeuchi H; Nozawa Y; Sato H; Nakatsue T; Wada Y; Moriyama H; Nakano M; Narita I
    BMC Res Notes; 2016 Apr; 9():240. PubMed ID: 27113212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy.
    Mori S; Cho I; Ichiyasu H; Sugimoto M
    Mod Rheumatol; 2008; 18(3):240-6. PubMed ID: 18306977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study.
    Kameda H; Tokuda H; Sakai F; Johkoh T; Mori S; Yoshida Y; Takayanagi N; Taki H; Hasegawa Y; Hatta K; Yamanaka H; Dohi M; Hashimoto S; Yamada H; Kawai S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2011; 50(4):305-13. PubMed ID: 21325762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors.
    Tanaka M; Sakai R; Koike R; Komano Y; Nanki T; Sakai F; Sugiyama H; Matsushima H; Kojima T; Ohta S; Ishibe Y; Sawabe T; Ota Y; Ohishi K; Miyazato H; Nonomura Y; Saito K; Tanaka Y; Nagasawa H; Takeuchi T; Nakajima A; Ohtsubo H; Onishi M; Goto Y; Dobashi H; Miyasaka N; Harigai M
    Mod Rheumatol; 2012 Nov; 22(6):849-58. PubMed ID: 22354637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study.
    Tokuda H; Sakai F; Yamada H; Johkoh T; Imamura A; Dohi M; Hirakata M; Yamada T; Kamatani N; Kikuchi Y; Sugii S; Takeuchi T; Tateda K; Goto H
    Intern Med; 2008; 47(10):915-23. PubMed ID: 18480575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of pneumocystis pneumonia complicated in patients with rheumatoid arthritis (RA) and non-RA rheumatic diseases.
    Yoshida Y; Takahashi Y; Minemura N; Ueda Y; Yamashita H; Kaneko H; Mimori A
    Mod Rheumatol; 2012 Aug; 22(4):509-14. PubMed ID: 21971942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumonia, pneumocystis pneumonia].
    Koike R; Harigai M
    Nihon Rinsho; 2007 Jul; 65(7):1314-20. PubMed ID: 17642249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration of the immune response induced by sulfamethoxazole-trimethoprim in a rheumatoid arthritis patient with Pneumocystis jirovecii pneumonia.
    Gochi M; Takayanagi N; Ishiguro T; Miyahara Y; Yanagisawa T; Shimizu Y; Sugita Y
    Intern Med; 2014; 53(11):1137-41. PubMed ID: 24881737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.
    Mori S; Cho I; Sugimoto M
    J Rheumatol; 2009 Aug; 36(8):1600-5. PubMed ID: 19531759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
    Koike R; Takeuchi T; Eguchi K; Miyasaka N;
    Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.
    Takeuchi T; Tatsuki Y; Nogami Y; Ishiguro N; Tanaka Y; Yamanaka H; Kamatani N; Harigai M; Ryu J; Inoue K; Kondo H; Inokuma S; Ochi T; Koike T
    Ann Rheum Dis; 2008 Feb; 67(2):189-94. PubMed ID: 17644554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.
    Imaizumi K; Sugishita M; Usui M; Kawabe T; Hashimoto N; Hasegawa Y
    Intern Med; 2006; 45(10):685-8. PubMed ID: 16778341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pneumocystis jiroveci pneumonia as a complication of glucocorticoid therapy for interstitial pneumonia].
    Enomoto T; Azuma A; Matsumoto A; Nei T; Hiramatsu K; Abe S; Usuki J; Kudoh S
    Nihon Kokyuki Gakkai Zasshi; 2005 Dec; 43(12):725-30. PubMed ID: 16457333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature.
    Kaneko Y; Suwa A; Ikeda Y; Hirakata M
    Mod Rheumatol; 2006; 16(1):36-8. PubMed ID: 16622722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.
    Kaur N; Mahl TC
    Dig Dis Sci; 2007 Jun; 52(6):1481-4. PubMed ID: 17429728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.
    Yukawa K; Nagamoto Y; Watanabe H; Funaki M; Iwahashi M; Yamana J; Sasaki R; Yamana S
    J Clin Rheumatol; 2018 Oct; 24(7):355-360. PubMed ID: 29664819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.